Roivant Sciences Ltd is a biopharmaceutical company that focuses on developing and commercializing innovative therapies to address unmet medical needs. The company's mission is to transform the way diseases are treated by leveraging advanced technologies and strategic partnerships.

From a technical analysis perspective, the stock of Roivant Sciences Ltd (RVT) is currently building a base within the context of an uptrend. A base refers to a period of consolidation and sideways movement in the stock's price, typically after a significant upward move. This pattern indicates that the stock is taking a pause and establishing a strong support level before potentially resuming its uptrend.

Traders and investors should closely monitor the price action and volume during the base-building phase to gauge the stock's strength and potential for further upside. A breakout above the base could signal a continuation of the uptrend and present potential buying opportunities.